Cargando…

Enriched environment ameliorates propagation of tau pathology and improves cognition in rat model of tauopathy

INTRODUCTION: The typical symptoms of Alzheimer’s disease (AD) are cognitive impairment, disrupted spatial orientation, behavioral and psychiatric abnormalities, and later motor deficits. Neuropathologically, AD is characterized by deposits of pathological forms of endogenous proteins – amyloid-β, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mate, Veronika, Smolek, Tomas, Kazmerova, Zuzana Vince, Jadhav, Santosh, Brezovakova, Veronika, Jurkanin, Bernadeta, Uhrinova, Ivana, Basheer, Neha, Zilka, Norbert, Katina, Stanislav, Novak, Petr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363241/ https://www.ncbi.nlm.nih.gov/pubmed/35966785 http://dx.doi.org/10.3389/fnagi.2022.935973

Ejemplares similares

Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of Tauopathy
por: Smolek, Tomas, et al.
Publicado: (2019)

Corrigendum: Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of Tauopathy
por: Smolek, Tomas, et al.
Publicado: (2020)

Truncated tau deregulates synaptic markers in rat model for human tauopathy
por: Jadhav, Santosh, et al.
Publicado: (2015)

Tau-mediated synaptic damage in Alzheimer’s disease
por: Jadhav, Santosh, et al.
Publicado: (2015)

Who fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways
por: Zilka, Norbert, et al.
Publicado: (2012)

Astrocytes Derived from Familial and Sporadic Alzheimer’s Disease iPSCs Show Altered Calcium Signaling and Respond Differently to Misfolded Protein Tau
por: Brezovakova, Veronika, et al.
Publicado: (2022)

Microglia display modest phagocytic capacity for extracellular tau oligomers
por: Majerova, Petra, et al.
Publicado: (2014)

Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease
por: Stozicka, Zuzana, et al.
Publicado: (2010)

Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer’s disease? From preclinical studies to the clinical trials
por: Basheer, Neha, et al.
Publicado: (2023)

GM3 Ganglioside Linked to Neurofibrillary Pathology in a Transgenic Rat Model for Tauopathy
por: Olešová, Dominika, et al.
Publicado: (2021)

The potential role of glial cells in driving the prion-like transcellular propagation of tau in tauopathies
por: Amro, Zein, et al.
Publicado: (2021)

Anterograde and Retrograde Propagation of Inoculated Human Tau Fibrils and Tau Oligomers in a Non-Transgenic Rat Tauopathy Model
por: Langer Horvat, Lea, et al.
Publicado: (2023)

Transcellular Spreading of Tau in Tauopathies
por: Demaegd, Koen, et al.
Publicado: (2018)

Promoting tau secretion and propagation by hyperactive p300/CBP via autophagy-lysosomal pathway in tauopathy
por: Chen, Xu, et al.
Publicado: (2020)

Are Tau Aggregates Toxic or Protective in Tauopathies?
por: Cowan, Catherine M., et al.
Publicado: (2013)

NMR Studies of Tau Protein in Tauopathies
por: Kitoka, Kristine, et al.
Publicado: (2021)

Risk factors for canine cognitive dysfunction syndrome in Slovakia
por: Katina, Stanislav, et al.
Publicado: (2016)

Nasal Rifampicin Halts the Progression of Tauopathy by Inhibiting Tau Oligomer Propagation in Alzheimer Brain Extract-Injected Mice
por: Umeda, Tomohiro, et al.
Publicado: (2022)

Enhanced Antiproliferative and Apoptotic Response of HT-29 Adenocarcinoma Cells to Combination of Photoactivated Hypericin and Farnesyltransferase Inhibitor Manumycin A
por: Sačková, Veronika, et al.
Publicado: (2011)

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model
por: Kontsekova, Eva, et al.
Publicado: (2014)

Impact of APOE genotype on prion-type propagation of tauopathy
por: Williams, Tristan, et al.
Publicado: (2022)

Tau exon 10 alternative splicing and tauopathies
por: Liu, Fei, et al.
Publicado: (2008)

Glial Tau Pathology in Tauopathies: Functional Consequences
por: Kahlson, Martha A., et al.
Publicado: (2016)

Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies
por: Fuster-Matanzo, Almudena, et al.
Publicado: (2018)

The Role of Microglia in the Spread of Tau: Relevance for Tauopathies
por: Perea, Juan R., et al.
Publicado: (2018)

Involvement of Oligodendrocytes in Tau Seeding and Spreading in Tauopathies
por: Ferrer, Isidro, et al.
Publicado: (2019)

Targeting tauopathy with engineered tau-degrading intrabodies
por: Gallardo, Gilbert, et al.
Publicado: (2019)

Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
por: Rawat, Priyanka, et al.
Publicado: (2022)

FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer’s disease
por: Novak, Petr, et al.
Publicado: (2018)

PET Imaging of Tau Pathology in Alzheimer’s Disease and Tauopathies
por: James, Olga G., et al.
Publicado: (2015)

Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
por: Laurent, Cyril, et al.
Publicado: (2018)

VPS35 regulates tau phosphorylation and neuropathology in tauopathy
por: Vagnozzi, Alana N., et al.
Publicado: (2021)

Colocalization of BRCA1 with Tau Aggregates in Human Tauopathies
por: Kurihara, Masanori, et al.
Publicado: (2019)

TBK1 interacts with tau and enhances neurodegeneration in tauopathy
por: Abreha, Measho H., et al.
Publicado: (2021)

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
por: Trojanowski, John Q
Publicado: (2013)

Phospho-Tau Bar Code: Analysis of Phosphoisotypes of Tau and Its Application to Tauopathy
por: Kimura, Taeko, et al.
Publicado: (2018)

Ten Years of Tau-Targeted Immunotherapy: The Path Walked and the Roads Ahead
por: Novak, Petr, et al.
Publicado: (2018)

P62 accumulates through neuroanatomical circuits in response to tauopathy propagation
por: Blaudin de Thé, François-Xavier, et al.
Publicado: (2021)

A simple human cell model for TAU trafficking and tauopathy-related TAU pathology
por: Bell, Michael, et al.
Publicado: (2021)

Tau(LUM), an in vivo Drosophila sensor of tau multimerization, identifies neuroprotective interventions in tauopathy
por: Levy, Simon A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g8nfohavj53d18cvvvsjrv57se